Analysts expect Cytosorbents Corp to report revenue of 10.24 M for Q3 26, against a range of 9.69 M to 10.79 M. The most recent reported quarter, Q2 26, came in at 9.63 M, a 0.6% miss against the 9.69 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 9.39 M | 9.20 M | 8.73 M | 9.62 M | 9.48 M | 9.23 M | 8.86 M | 9.63 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 11.19 M | 10.47 M | 9.18 M | 9.41 M | 10.52 M | 9.87 M | 9.08 M | 10.27 M | 10.79 M | 10.56 M | 12.03 M | 12.94 M | 11.08 M | 11.87 M | 12.29 M | 13.45 M | ||||||||||
| Low Estimate | 10.09 M | 8.93 M | 7.93 M | 7.88 M | 9.42 M | 8.42 M | 8.40 M | 9.10 M | 9.69 M | 9.17 M | 10.91 M | 11.14 M | 10.10 M | 10.09 M | 10.85 M | 12.30 M | ||||||||||
| Consensus Estimate | 10.64 M | 9.70 M | 8.56 M | 8.65 M | 9.97 M | 9.14 M | 8.74 M | 9.69 M | 10.24 M | 9.87 M | 11.47 M | 12.04 M | 10.59 M | 10.98 M | 11.57 M | 12.87 M |
Analysts expect Cytosorbents Corp to report earnings per share of -0.95 for Q3 26, against a range of -1.00 to -0.90. The most recent reported quarter, Q2 26, came in at -1.00, a 5.3% miss against the -0.95 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.80 | -2.80 | -0.40 | 0.60 | -0.80 | -1.80 | -1.00 | -1.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.28 | -1.03 | -1.38 | -1.11 | -0.73 | -0.99 | -1.09 | -0.91 | -0.90 | -0.63 | 0.00 | 0.00 | -0.44 | -0.42 | 0.61 | 0.51 | ||||||||||
| Low Estimate | -1.40 | -1.17 | -1.50 | -1.29 | -0.79 | -1.15 | -1.23 | -0.99 | -1.00 | -0.69 | 0.00 | 0.00 | -0.52 | -0.46 | 0.51 | 0.43 | ||||||||||
| Consensus Estimate | -1.34 | -1.10 | -1.44 | -1.20 | -0.76 | -1.07 | -1.16 | -0.95 | -0.95 | -0.66 | 0.00 | 0.00 | -0.48 | -0.44 | 0.56 | 0.47 |
Pull Wall Street consensus for Cytosorbents Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CTSO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CTSO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CTSO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();